Literature DB >> 15195307

Total synthesis and biological evaluation of the protein phosphatase 2A inhibitor cytostatin and analogues.

Laurent Bialy1, Herbert Waldmann.   

Abstract

The total synthesis of the natural product cytostatin is described which inhibits protein phosphatase 2A. Cytostatin has anti-metastatic properties and induces apoptosis. On the basis of this synthesis the relative and absolute configuration of cytostatin could be assigned. Key structural elements of cytostatin are an alpha,beta-unsaturated lactone group and a side chain embodying a phosphate and a rather unstable (Z,Z,E)-triene subunit. In addition, the natural product carries six stereocenters. For the construction of the stereocenters reagent-controlled transformations were used in order to ensure maximum stereochemical flexibility. The Evans syn-aldol reaction was chosen to establish the stereochemistry at C-4, C-5, C-9 and C-10; C-6 was introduced by means of the Evans asymmetric alkylation. In all cases the same chiral auxiliary was employed as stereodirecting group. The stereocenter at C-11 was established by an asymmetric reduction using CBS-oxazaborolidine. Temporary protection of the phosphate group was achieved best by using the base-labile 9-fluorenylmethyl group, which could be cleanly cleaved by an excess of triethylamine; this reaction yielded analytically pure phosphates after a simple aqueous work-up. The (Z,Z,E)-triene embodied in cytostatin was synthesized by means of a Stille coupling as key transformation. The synthesis sequence established in this way readily gave access to a series of analogues with simplified structure. Initial biological testing of these analogues proved that the alpha,beta-unsaturated lactone, the C-11-hydroxy group and a fully deprotected phosphate moiety at C-9 are essential for the PP2A-inhibitory activity of cytostatin. The rather unstable triene moiety in the side chain can be replaced by other lipophilic residues with only moderate decrease of biological activity. Other phosphatases, that is, PP1, VHR, PTP1B, CD45, were not inhibited by cytostatin or any of the analogues, demonstrating the high selectivity of this compound. These findings will be useful for the design and synthesis of cytostatin-derived chemical tools for the study of biological processes influenced by PP2A.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15195307     DOI: 10.1002/chem.200305543

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  10 in total

1.  Total synthesis and evaluation of cytostatin, its C10-C11 diastereomers, and additional key analogues: impact on PP2A inhibition.

Authors:  Brian G Lawhorn; Sobhana B Boga; Scott E Wolkenberg; David A Colby; Carla-Maria Gauss; Mark R Swingle; Lauren Amable; Richard E Honkanen; Dale L Boger
Journal:  J Am Chem Soc       Date:  2006-12-27       Impact factor: 15.419

Review 2.  Synthetic Strategies Employed for the Construction of Fostriecin and Related Natural Products.

Authors:  Barry M Trost; Joshua D Knopf; Cheyenne S Brindle
Journal:  Chem Rev       Date:  2016-12-08       Impact factor: 60.622

3.  Total synthesis of fostriecin: via a regio- and stereoselective polyene hydration, oxidation, and hydroboration sequence.

Authors:  Dong Gao; George A O'Doherty
Journal:  Org Lett       Date:  2010-09-03       Impact factor: 6.005

Review 4.  De novo synthesis of natural products via the asymmetric hydration of polyenes.

Authors:  Yanping Wang; Yalan Xing; Qi Zhang; George A O'Doherty
Journal:  Chem Commun (Camb)       Date:  2011-05-11       Impact factor: 6.222

5.  Structure-activity relationship studies of fostriecin, cytostatin, and key analogs, with PP1, PP2A, PP5, and( beta12-beta13)-chimeras (PP1/PP2A and PP5/PP2A), provide further insight into the inhibitory actions of fostriecin family inhibitors.

Authors:  Mark R Swingle; Lauren Amable; Brian G Lawhorn; Suzanne B Buck; Christopher P Burke; Pukar Ratti; Kimberly L Fischer; Dale L Boger; Richard E Honkanen
Journal:  J Pharmacol Exp Ther       Date:  2009-07-10       Impact factor: 4.030

6.  Total synthesis and evaluation of phostriecin and key structural analogues.

Authors:  Christopher P Burke; Mark R Swingle; Richard E Honkanen; Dale L Boger
Journal:  J Org Chem       Date:  2010-07-29       Impact factor: 4.354

7.  Total synthesis, assignment of the relative and absolute stereochemistry, and structural reassignment of phostriecin (aka Sultriecin).

Authors:  Christopher P Burke; Nadia Haq; Dale L Boger
Journal:  J Am Chem Soc       Date:  2010-02-24       Impact factor: 15.419

8.  Substrate and product analogues as human O-GlcNAc transferase inhibitors.

Authors:  Helge C Dorfmueller; Vladimir S Borodkin; David E Blair; Shalini Pathak; Iva Navratilova; Daan M F van Aalten
Journal:  Amino Acids       Date:  2010-07-17       Impact factor: 3.520

9.  A short stereoselective synthesis of (+)-(6R,2'S)-cryptocaryalactone via ring-closing metathesis.

Authors:  Palakodety Radha Krishna; Krishnarao Lopinti; K L N Reddy
Journal:  Beilstein J Org Chem       Date:  2009-04-24       Impact factor: 2.883

10.  Mechanistic insights into the three steps of poly(ADP-ribosylation) reversal.

Authors:  Johannes Gregor Matthias Rack; Qiang Liu; Valentina Zorzini; Jim Voorneveld; Antonio Ariza; Kourosh Honarmand Ebrahimi; Julia M Reber; Sarah C Krassnig; Dragana Ahel; Gijsbert A van der Marel; Aswin Mangerich; James S O McCullagh; Dmitri V Filippov; Ivan Ahel
Journal:  Nat Commun       Date:  2021-07-28       Impact factor: 14.919

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.